Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy

Jinyu Zhang (Creator)
Pablo Saenz Lopez Larrocha (Creator)
Bin Zhang (Creator)
Derek Wainwright (Creator)
Payal Dhar (Contributor)
Jennifer Donglan Wu (Creator)

Dataset

1 Article

1 results

2019
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC⁺ tumors respond to PD1/PD-L1 blockade therapy
Zhang, J., Larrocha, P. S. L., Zhang, B., Wainwright, D., Dhar, P. & Wu, J. D., Aug 26 2019, In: Journal for immunotherapy of cancer. 7, 1, 223.
Research output: Contribution to journal › Article › peer-review

Open Access
17 Scopus citations